Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation

SJ Singh, MM Baldwin, E Daynes, RA Evans… - The Lancet …, 2023 - thelancet.com
Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

[HTML][HTML] Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind …

CT Bramante, JB Buse, DM Liebovitz… - The Lancet Infectious …, 2023 - thelancet.com
Summary Background Post-COVID-19 condition (also known as long COVID) is an
emerging chronic illness potentially affecting millions of people. We aimed to evaluate …

Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19

CT Bramante, JD Huling, CJ Tignanelli… - … England Journal of …, 2022 - Mass Medical Soc
Background Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an
important component of the comprehensive response to the severe acute respiratory …

Cholinergic dysfunction in COVID-19: frantic search and ho** for the best

EH Nadwa, HM Al-Kuraishy, AI Al-Gareeb… - Naunyn-schmiedeberg's …, 2023 - Springer
A novel coronavirus known as severe acute respiratory syndrome coronavirus type 2 (SARS-
CoV-2) is a potential cause of acute respiratory infection called coronavirus disease 2019 …

The SARS-CoV-2 RNA Interactome

S Lee, Y Lee, Y Choi, A Son, Y Park, KM Lee, J Kim… - Molecular cell, 2021 - cell.com
SARS-CoV-2 is an RNA virus whose success as a pathogen relies on its abilities to
repurpose host RNA-binding proteins (RBPs) and to evade antiviral RBPs. To uncover the …

A review: understanding molecular mechanisms of antibody-dependent enhancement in viral infections

J Sawant, A Patil, S Kurle - Vaccines, 2023 - mdpi.com
Antibody Dependent Enhancement (ADE) of an infection has been of interest in the
investigation of many viruses. It is associated with the severity of the infection. ADE is …

Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up

CT Bramante, JB Buse, D Liebovitz, J Nicklas… - medRxiv, 2022 - pmc.ncbi.nlm.nih.gov
Background Long Covid is an emerging chronic illness potentially affecting millions,
sometimes preventing the ability to work or participate in normal daily activities. COVID-OUT …

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies

GA Sánchez-Zuno, MG Matuz-Flores… - International journal …, 2021 - journals.sagepub.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), represents an unprecedented global public health …

A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19

G Mostafa-Hedeab, HM Al-Kuraishy, AI Al-Gareeb… - …, 2022 - Springer
The existing pandemic viral infection caused by severe acute respiratory syndrome
coronavirus type 2 (SARS-CoV-2) leads to coronavirus disease 2019 (Covid-19). SARS …

Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era

BP Verdoorn, TK Evans, GJ Hanson… - Journal of the …, 2021 - Wiley Online Library
The burden of senescent cells (SnCs), which do not divide but are metabolically active and
resistant to death by apoptosis, is increased in older adults and those with chronic diseases …